Literature DB >> 19782430

Risk factors for nosocomial infection during extracorporeal membrane oxygenation.

M-S Hsu1, K-M Chiu, Y-T Huang, K-L Kao, S-H Chu, C-H Liao.   

Abstract

An increasing number of patients receive extracorporeal membrane oxygenation (ECMO) for life support. This study aimed to investigate the incidence and risk factors for nosocomial infection in adult patients receiving ECMO. We reviewed the medical records of adult patients who received ECMO support for more than 72h at Far Eastern Memorial Hospital from 2001 to 2007. ECMO-related nosocomial infections were defined as infections occurring from 24h after ECMO initiation until 48h after ECMO discontinuation. There were 12 episodes of nosocomial infection identified in 10 of the 114 (8.77%) patients on ECMO, including four cases of pneumonia, three cases of bacteraemia, three surgical site infections and two urinary tract infections. The incidence of ECMO-related nosocomial infection was 11.92 per 1000 ECMO-days. The length of ECMO use and intensive care unit (ICU) stay were significantly different between patients with, and without, nosocomial infection (P<0.001). More than 10 days of ECMO use was associated with a significantly higher nosocomial infection rate (P=0.003). Gram-negative bacilli were responsible for 78% of the nosocomial infections. In the univariate analysis, the duration of ICU stay and duration of ECMO use were associated with nosocomial infection. In the multivariate analysis, only the duration of ECMO was independently associated with nosocomial infection (P=0.007). Overall, the only independent risk factor for ECMO-related nosocomial infection identified in this study was prolonged ECMO use.

Entities:  

Mesh:

Year:  2009        PMID: 19782430     DOI: 10.1016/j.jhin.2009.07.016

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  34 in total

1.  Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.

Authors:  Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Ron A Mathot
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Understanding the long-term sequelae of ECMO survivors.

Authors:  Stacey Burns; Natalie Constantin; Priscila Robles
Journal:  Intensive Care Med       Date:  2017-02-16       Impact factor: 17.440

3.  Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review.

Authors:  Benjamin J Parcell; Pavan Kumar B C Raju; Elizabeth M Johnson; Thomas C Fardon; William J Olver
Journal:  Med Mycol Case Rep       Date:  2014-02-10

4.  Impact of bloodstream infections on catheter colonization during extracorporeal membrane oxygenation.

Authors:  Dong Wan Kim; Hye Ju Yeo; Seong Hoon Yoon; Seung Eun Lee; Su Jin Lee; Woo Hyun Cho; Doo Soo Jeon; Yun Seong Kim; Bong Soo Son; Do Hyung Kim
Journal:  J Artif Organs       Date:  2015-12-31       Impact factor: 1.731

Review 5.  Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.

Authors:  Kevin Watt; Paolo Manzoni; Michael Cohen-Wolkowiez; Stefano Rizzollo; Elena Boano; Evelyne Jacqz-Aigrain; Daniel K Benjamin
Journal:  Curr Drug Metab       Date:  2013-02       Impact factor: 3.731

6.  Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation.

Authors:  Matthieu Schmidt; Nicolas Bréchot; Sarah Hariri; Marguerite Guiguet; Charles Edouard Luyt; Ralouka Makri; Pascal Leprince; Jean-Louis Trouillet; Alain Pavie; Jean Chastre; Alain Combes
Journal:  Clin Infect Dis       Date:  2012-09-18       Impact factor: 9.079

Review 7.  Trends in and perspectives on extracorporeal membrane oxygenation for severe adult respiratory failure.

Authors:  Tomohito Sadahiro; Shigeto Oda; Masataka Nakamura; Yo Hirayama; Eizo Watanabe; Yoshihisa Tateishi; Koichiro Shinozaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

8.  High-Frequency Percussive Ventilation Facilitates Weaning from Extracorporeal Membrane Oxygenation in Adults.

Authors:  Iosif Gulkarov; James Schiffenhaus; Ivan Wong; Ashwad Afzal; Felix Khusid; Berhane Worku
Journal:  J Extra Corpor Technol       Date:  2018-03

9.  Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.

Authors:  Ahmed A Mahmoud; Sean N Avedissian; Abbas Al-Qamari; Tiffany Bohling; Michelle Pham; Marc H Scheetz
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447

10.  Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Jin Wi; Hayeon Noh; Kyoung Lok Min; Seungwon Yang; Byung Hak Jin; Jongsung Hahn; Soo Kyung Bae; Jiseon Kim; Min Soo Park; Donghoon Choi; Min Jung Chang
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.